Contracts reveal details about Covid-19 vaccine deals in South Africa; Astella withdraws drug pricing negotiation lawsuit

Taking stock of the drug industry, from the lab to the medicine chest

September 6, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Jon Cherry/Getty Images STAT+ | South Africa was forced into 'one-sided' deals with Covid-19 vaccine suppliers, contracts reveal "We were bullied into unfair and undemocratic terms in contracts that were totally one-sided," sad Fatima Hassan of Health Justice Initiative. By Ed Silverman STAT+ | AstraZeneca CEO Pascal Soriot proposes a novel fix to the drug pricing bill's alleged cancer problem Among the pharmaceutical companies' many objections to the Biden administration's drug pricing program is a set of provisions the industry says will warp how cancer drugs are developed. On Wednesday, AstraZeneca CEO Pascal Soriot proposed a new solution. "What we were asking — and are asking now — is a very simple fix," said Soriot at the STAT Future Summit, saying that "the impact on healthcare would be very marginal." By Jason Mast STAT+ | Astellas withdraws lawsuit after evading Medicare drug price negotiations Astellas was so sure that one of its drugs was going to be selected as part of Medicare's drug price negotiations that it preemptively sued. By Rachel Cohrs J. Scott Applewhite/AP STAT+ | House committees strike deal on health transparency, PBM reform package Republicans on three key House committees have reconciled differing legislative packages to increase transparency in the health care system. By Rachel Cohrs Opinion: What does 'bona fide competition' actually mean in the biologics market? For the first time, originator biologics firms' success in extending their exclusivity comes with the potential for associated costs. By Arti K. Rai STAT+ | Cancer care appears brighter as off-the-shelf CAR-T advances Allogeneic approach could bring cell therapy to more patients more quickly, biopharma executives say. By Elizabeth Cooney

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser